To see the other types of publications on this topic, follow the link: Clostidium botulinum type E.

Books on the topic 'Clostidium botulinum type E'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 26 books for your research on the topic 'Clostidium botulinum type E.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Moriarty, Kate Coleman. Botulinum toxin in facial rejuvenation. Mosby, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Benedetto, Anthony V. Botulinum toxins in clinical aesthetic practice. 2nd ed. Informa Healthcare, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Botulinum toxins in clinical aesthetic practice. 2nd ed. Informa Healthcare, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

K, Gadre Arun, Muller Chris MD, and American Academy of Otolaryngology--Head and Neck Surgery Foundation., eds. Botulinum toxin in otolaryngology: A practical guide. American Academy of Otolaryngology--Head and Neck Surgery Foundation, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dover, Jeffrey S., Jean Carruthers, Alastair Carruthers, and Murad Alam. Botulinum Toxin. Elsevier - Health Sciences Division, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Alastair, Carruthers, and Carruthers Jean, eds. Botulinum toxin: Cosmetic and medical uses. Elsevier Saunders, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Coleman-Moriarty, Kate. Botulinum Toxin in Facial Rejuvenation. Mosby, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Childers, Martin K. The Use of Botulinum Toxin Type A in Pain Management. 2nd ed. Greenleaf Book Group, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Benedetto, Anthony V. Botulinum Toxins in Clinical Aesthetic Practice. Taylor & Francis Group, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Dover, Jeffrey S., Jean Carruthers, Alastair Carruthers, and Murad Alam. Botulinum Toxin: Procedures in Cosmetic Dermatology Series. Elsevier - Health Sciences Division, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Botulinum Toxin in Painful Diseases (Pain and Headache). S. Karger Publishers (USA), 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Childers, Martin K. Use of Botulinum Toxin Type A in Pain Management: A Clinician's Guide. Demos Medical Publishing, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Carruthers, Jean, and Alastair Carruthers. Procedures in Cosmetic Dermatology Series: Botulinum Toxin: Textbook with DVD. Saunders, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Moncarz, Andrew Stuart. Facilitation of physiotherapy for patients suffering from myalgia using botulinum toxin type-A. 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kirsten, Garces, and Canadian Coordinating Office for Health Technology Assessment., eds. Botulinum toxin A for upper and lower limb spasticity: A systematic review. Canadian Coordinating Office for Health Technology Assessment, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

F, Brin Mitchell, Spasticity Study Group, and WE MOVE (Organization), eds. Spasticity: Etiology, evaluation, management, and the role of botulinum toxin type A ; a training syllabus. John Wiley & Sons, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Botulinum Toxins in Clinical Aesthetic Practice: Functional Anatomy and Injection Techniques. Taylor & Francis Group, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Carruthers, Jean, and Alastair Carruthers. Procedures in Cosmetic Dermatology Series: Botulinum Toxin with DVD (Procedures in Cosmetic Dermatology). 2nd ed. Saunders, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

(Editor), Benjamin Ascher, Marina Landau (Editor), and Bernard Rossi (Editor), eds. Injection Treatments in Cosmetic Surgery (Series in Cosmetic and Laser Therapy). Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Benjamin, Ascher, Landau Marina, and Rossi Bernard, eds. Injection treatments in cosmetic surgery. 2nd ed. Informa Healthcare, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Company, Milady Publishing, ed. Professional services for men: Haircoloring and hair restoration. Thomson Delmar Learning, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Mowafak, Abdelghani. Botox analgesia for neuropathic pain. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0072.

Full text
Abstract:
The landmark paper discussed in this chapter is ‘Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain’, published by Ranoux et al. in 2008. The muscle-relaxant properties of botulinum toxin type A (BTX-A) have long been known and used therapeutically. However, BTX-A actions independent of those affecting neuromuscular function had previously only been alluded to, via the observation that BTX-A injections alleviated pain more than would have been expected through the treatment of muscle spasm alone. This paper was one of the first to specifically examine the efficacy of BTX-A in neuropathic pain and was a catalyst for further investigation into BTX-A as a novel analgesic.
APA, Harvard, Vancouver, ISO, and other styles
26

Shaibani, Aziz. Facial Weakness. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190661304.003.0005.

Full text
Abstract:
Unilateral or bilateral facial weakness is an important manifestation of many neuromuscular disorders; some of them are as simple as Bell’s palsy, while others are as serious as Guillain-Barré syndrome (GBS). Facial weakness can be easily mimicked, and therefore, psychogenic etiology should always be kept in mind. Peripheral facial weakness affects all functions and parts, while central weakness may save the upper face and may affect emotional and voluntary functions differentially. Botulinum toxin injection has become a common cause of facial palsy, therefore detailed history is crucial. Examination of the sensory and motor systems is important to define the type and cause. Imaging and electrodiagnostic testing are often needed in the diagnostic process.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!